Benoxinate Hydrochloride; Fluorescein Sodium is Used for facilitating ocular procedures and examinations in patients requiring a disclosing agent with a topical ophthalmic anesthetic. It was first introduced by Altaire Pharmaceuticals Inc in its drug Altafluor Benox on Dec 14, 2017. Another drug containing Benoxinate Hydrochloride; Fluorescein Sodium is Fluorescein Sodium And Benoxinate Hydrochloride. 2 different companies have introduced drugs containing Benoxinate Hydrochloride; Fluorescein Sodium.

Benoxinate Hydrochloride; Fluorescein Sodium Patents

Given below is the list of patents protecting Benoxinate Hydrochloride; Fluorescein Sodium, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Fluorescein Sodium And Benoxinate Hydrochloride	US10293047	Fluorescein and benoxinate compositions	Nov 15, 2037	Bausch Lomb Ireland
Fluorescein Sodium And Benoxinate Hydrochloride	US10632197	Fluorescein and benoxinate compositions	Nov 15, 2037	Bausch Lomb Ireland
Fluorescein Sodium And Benoxinate Hydrochloride	US10842872	Fluorescein and benoxinate compositions	Nov 15, 2037	Bausch Lomb Ireland

Add above patents to watchlist

Benoxinate Hydrochloride; Fluorescein Sodium's Family Patents

Full family tree